drugset
Drugs / PLASMA PROTEIN FRACTION
last change Sep 2021 re-read 2 minutes ago

PLASMA PROTEIN FRACTION

also known as Human plasma protein · human plasma protein fraction · Human plasma proteins · Plasma protein · Plasma protein fraction (human) · PPF · Protein/MF59

Vaccine

Developed for
HIV infectious disease
Investigated by
Hamad Medical Corporation

Trials 1 · a red edge is where a trial was stopped

today NCT05033704 · not/applicable
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT05033704 Sep 2019 → Sep 2021 disorder of mineral absorption and transport, disseminated intravascular coagulation Hamad Medical Corporation Unknown No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02997969 Comparator Jun 2016 → Jul 2018 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as PLASMA PROTEIN FRACTION ChEMBL registry synonym — accepted as the source's own label CHEMBL2108773 ↗
Known as Human plasma protein ChEMBL registry synonym — accepted as the source's own label CHEMBL2108773 ↗
Known as human plasma protein fraction ClinicalTrials.gov intervention name — accepted as the source's own label NCT05033704 ↗
Known as Human plasma proteins ChEMBL registry synonym — accepted as the source's own label CHEMBL2108773 ↗
Known as Plasma protein ChEMBL registry synonym — accepted as the source's own label CHEMBL2108773 ↗
Known as Plasma protein fraction (human) ChEMBL registry synonym — accepted as the source's own label CHEMBL2108773 ↗
Known as PPF “Infusion of 5% human plasma protein fraction PPF.” NCT05033704 ↗
Known as Protein/MF59 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02997969 ↗
Modality Vaccine “Protein/MF59 vaccine” NCT02997969 ↗
Route Intramuscular “administered as 0.5 mL IM” NCT02997969 ↗